nsc-638718 and Sarcoma--Synovial

nsc-638718 has been researched along with Sarcoma--Synovial* in 1 studies

Other Studies

1 other study(ies) available for nsc-638718 and Sarcoma--Synovial

Article	Year
Pericardial synovial sarcoma: 14-year survival with multimodality therapy. The Annals of thoracic surgery, 2004, Volume: 78, Issue:3 We report a case of recurrent primary synovial sarcoma of the pericardium. Reverse transcriptase-polymerase chain reaction analysis for t(X,18) demonstrated the presence of the chimeric transcript SYT/SSX. Because of the rarity of this entity, optimal therapy is unknown. The prognosis of this tumor is very poor in previous reports. In this report, we present a case with five recurrences treated by a combination of surgery, chemotherapy, and radiotherapy. The patient survives now for more than 14 years, the longest reported survival of a primary synovial sarcoma of the pericardium. Topics: Adult; Chemotherapy, Adjuvant; Dimethoate; Disease Progression; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Isoquinolines; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Palliative Care; Pericardium; Sarcoma, Synovial; Tomography, X-Ray Computed; Treatment Outcome	2004

Article

Year

Pericardial synovial sarcoma: 14-year survival with multimodality therapy.

The Annals of thoracic surgery, 2004, Volume: 78, Issue:3

We report a case of recurrent primary synovial sarcoma of the pericardium. Reverse transcriptase-polymerase chain reaction analysis for t(X,18) demonstrated the presence of the chimeric transcript SYT/SSX. Because of the rarity of this entity, optimal therapy is unknown. The prognosis of this tumor is very poor in previous reports. In this report, we present a case with five recurrences treated by a combination of surgery, chemotherapy, and radiotherapy. The patient survives now for more than 14 years, the longest reported survival of a primary synovial sarcoma of the pericardium.

Topics: Adult; Chemotherapy, Adjuvant; Dimethoate; Disease Progression; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Isoquinolines; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Palliative Care; Pericardium; Sarcoma, Synovial; Tomography, X-Ray Computed; Treatment Outcome

2004